INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 183 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,228,000 | +148.7% | 50,260 | +33.2% | 1.44% | +124.5% |
| Q3 2019 | $2,504,000 | -17.3% | 37,734 | -0.9% | 0.64% | -10.9% |
| Q2 2019 | $3,029,000 | -28.7% | 38,073 | +0.3% | 0.72% | -32.6% |
| Q1 2019 | $4,247,000 | +110.5% | 37,970 | +89.6% | 1.06% | +74.9% |
| Q4 2018 | $2,018,000 | -47.5% | 20,025 | -34.1% | 0.61% | -33.2% |
| Q3 2018 | $3,841,000 | +1019.8% | 30,395 | +1281.6% | 0.91% | +785.4% |
| Q4 2014 | $343,000 | -34.2% | 2,200 | 0.0% | 0.10% | -35.6% |
| Q3 2014 | $521,000 | 0.0% | 2,200 | 0.0% | 0.16% | -2.4% |
| Q2 2014 | $521,000 | -28.2% | 2,200 | 0.0% | 0.16% | -32.0% |
| Q1 2014 | $726,000 | +165.9% | 2,200 | -45.0% | 0.24% | +159.1% |
| Q4 2013 | $273,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |